“Adjuvant Topical Dorzolamide or Timolol With Intravitreal Bevacizumab for Diabetic Macular Edema: A Double-Blind Randomized Controlled Trial”. Journal of Current Biomedical Reports, vol. 5, no. 1, Mar. 2024, pp. 14-19, https://doi.org/10.61882/jcbior.5.1.279.